{
    "medicine_id": "ee7f6723c83049ced051314f50cdf3cc93ff1ffc",
    "platform_id": "DB09336",
    "metadata": {
        "name": "Trovan I V Liquid",
        "composition": "Technetium Tc 99m nofetumomab merpentan",
        "clinical_particulars": {
            "therapeutic_indications": "Tc 99m nm is one of the technetium labeled antibodies and it is indicated for the detection of small cell lung cancer L1146 The small cell lung cancer is a syndrome characterized by the abnormal and uncontrolled cell growth and it is characterized by a shorter doubling time higher growth fraction and earlier development of metastases L1651",
            "contraindications": {
                "disease": "Long term preclinical studies to determine the carcinogenic mutagenic or fertility effect have not been studied FDA label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Studies have shown that the Fab fragment presents high immunoreactivity in small cell lung cancer tumors The adenocarcinomas of the kidney and pancreas are not detected This lack of diagnostic detection can be explained because some radioactivity gets accumulated in the excretion pathway in nonspecific vascular locations and in non tumor areas with traces of inflammation increased vascular pool or recent surgical Therefore the detection rate may be reduced in those areas and its adjacent zones FDA Label",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}